Concepedia

Tanya Jindal

TJ

9

Publications

217

Citations

9

H-Index

2021

Active since

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

University of Washington

Fred Hutch Cancer Center

Cleveland Clinic

Tanya Jindal is an author at University of California, San Francisco specializing in cancer therapeutics, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

2021–2024

9

Publications

9

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Vadim S. Koshkin, Nicholas Henderson, Marihella James et al. · Cancer · 2021 · 80 citations · Full text

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience

Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin et al. · Clinical Genitourinary Cancer · 2023 · 26 citations · Full text

, , +8

Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

Dimitrios Makrakis, Dimitra Rafailia Bakaloudi, Rafee Talukder et al. · Clinical Genitourinary Cancer · 2022 · 22 citations · Full text

Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations

Joseph J. Park, Alec Chu, Jinju Li et al. · JCO Precision Oncology · 2024 · 19 citations · Full text

Outcomes in patients (pts) with advanced urothelial carcinoma (aUC) treated with enfortumab vedotin (EV) after switch maintenance avelumab (MAv) in the UNITE study.

Amanda Nizam, Tanya Jindal, Cindy Jiang et al. · Journal of Clinical Oncology · 2024 · 16 citations

, , +20

Rows per page

1–5 of 9